EU official says agency hasn't got Covishield approval request: Report

Individual member states will have the option to accept vaccines that have been authorised by the WHO, says the EU offical

Covishield
Photo: PTI
BS Web Team New Delhi
2 min read Last Updated : Jun 29 2021 | 2:26 PM IST
The European Medical Agency (EMA) has not received any request for approval of Covishield in its vaccine certificate list, news agency ANI reported citing an EU official.

"Concerning a possible EMA authorisation for Covishield, as of yesterday, the EMA stated that it had not received a request for approval. It will examine any such request when received, as per its procedures," the official was quoted as saying by ANI.

"The EU digital certificate is meant to facilitate safe free movement during the pandemic within the region. It will serve as proof that a person was vaccinated and received a negative test result or recovered from it. It is not a pre-condition to travel," he further said.

The official also said that individual member states will have the option to accept vaccines that have been authorised by the World Health Organization (WHO). Covishield has been included in the WHO's emergency listing.

There have been multiple reports that those who have taken Serum Institute of India (SII)-produced AstraZeneca vaccine will face challenges in travelling to Europe. 

The CEO of Pune-based vaccina maker, Adar Poonawalla on Monday, said, that he has taken it up at the ‘highest levels’ both with regulators and at a diplomatic level with countries.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story